Sang Yi - Feb 25, 2024 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Role
Group President, Asia Pacific
Signature
/s/ Matthew R. St. Louis, Attorney-in-Fact for Sang Yi (power of attorney previously filed)
Stock symbol
ZBH
Transactions as of
Feb 25, 2024
Transactions value $
$0
Form type
4
Date filed
2/27/2024, 08:55 PM
Previous filing
Feb 22, 2024
Next filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZBH Common Stock Options Exercise $0 +5.05K +57.91% $0.00 13.8K Feb 25, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZBH Restricted Stock Units Options Exercise $0 -5.05K -100% $0.00* 0 Feb 25, 2024 Common Stock 5.05K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.
F2 Includes 188 shares acquired under the Company's Employee Stock Purchase Plan and pursuant to dividend reinvestment through February 1, 2024.
F3 Each RSU represents a contingent right to receive one share of Company common stock.